Real-time enrollment status for this carcinoma, non-small-cell lung clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 6:54 AM UTC
| NCT Number | NCT05208762 |
| Recruiting Status | Recruiting |
| Condition | Carcinoma, Non-Small-Cell Lung |
| Phase | PHASE1 |
| Target Enrollment | 714 participants |
| Active Locations | 25 sites in the US |
| Sponsor | Seagen, a wholly owned subsidiary of Pfizer |
| Last Updated on CT.gov | July 22, 2026 (Jul 22, 2026) |
As of August 28, 2026: Clinical trial NCT05208762 is currently recruiting participants. This phase1 study for carcinoma, non-small-cell lung is actively seeking new participants at 25 locations across the United States. The study is sponsored by Seagen, a wholly owned subsidiary of Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05208762 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 25 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05208762 was last updated Jul 22, 2026 (July 22, 2026). HelloStudys verifies this status automatically.